New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate

被引：12

作者：

Davis, JC

Huang, F

Maksymowych, W

机构：

[1] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA

[2] Chinese Peoples Liberat Army Gen Hosp, Dept Rheumatol, Beijing 100853, Peoples R China

[3] Univ Alberta, Dept Med, Div Rheumatol, Heritage Med Res Ctr 562, Edmonton, AB T6G 2S2, Canada

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2003年 / 29卷 / 03期

基金：

中国国家自然科学基金; 美国国家卫生研究院;

关键词：

D O I：

10.1016/S0889-857X(03)00028-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Ankylosing spondylitis is the most common of a group of diseases called the seronegative spondyloarthropathies. This group of diseases shares common demographic, clinical, and genetic features. This article reviews the rationale, clinical efficacy, and safety reports of etanercept, thalidomide, and pamidronate in the treatment of patients who have ankylosing spondylitis.

引用

页码：481 / +

页数：15

共 52 条

[1] THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].

ADAMI, S ;

BHALLA, AK ;

DORIZZI, R ;

MONTESANTI, F ;

ROSINI, S ;

SALVAGNO, G ;

LOCASCIO, V .

CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331

[2] STUDIES ON THE CHRONIC PHASE OF ADJUVANT ARTHRITIS - EFFECT OF SR-41319, A NEW DIPHOSPHONATE [J].

BARBIER, A ;

BRELIERE, JC ;

REMANDET, B ;

RONCUCCI, R .

ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (01) :67-74

[3] APD IN PAGETS-DISEASE OF BONE - ROLE OF THE MONONUCLEAR PHAGOCYTE SYSTEM [J].

BIJVOET, OLM ;

FRIJLINK, WB ;

JIE, K ;

VANDERLINDEN, H ;

MEIJER, CJLM ;

MULDER, H ;

VANPAASSEN, HC ;

REITSMA, PH ;

TEVELDE, J ;

DEVRIES, E ;

VANDERWEY, JP .

ARTHRITIS AND RHEUMATISM, 1980, 23 (10) :1193-1204

[4]

Brandt J, 2002, ARTHRITIS RHEUM-US, V46, pS429

[5] USE OF IMMUNOHISTOLOGIC AND IN-SITU HYBRIDIZATION TECHNIQUES IN THE EXAMINATION OF SACROILIAC JOINT BIOPSY SPECIMENS FROM PATIENTS WITH ANKYLOSING-SPONDYLITIS [J].

BRAUN, J ;

BOLLOW, M ;

NEURE, L ;

SEIPELT, E ;

SEYREKBASAN, F ;

HERBST, H ;

EGGENS, U ;

DISTLER, A ;

SIEPER, J .

ARTHRITIS AND RHEUMATISM, 1995, 38 (04) :499-505

[6] Efficacy of infliximab in refractory ankylosing spondylitis:: results of a six-month open-label study [J].

Breban, M ;

Vignon, E ;

Claudepierre, P ;

Devauchelle, V ;

Wendling, D ;

Lespessailles, E ;

Euller-Ziegler, L ;

Sibilia, J ;

Perdriger, A ;

Mezières, M ;

Alexandre, C ;

Dougados, M .

RHEUMATOLOGY, 2002, 41 (11) :1280-1285

[7]

Breban M, 1999, ARTHRITIS RHEUM, V42, P580, DOI 10.1002/1529-0131(199904)42:3<580::AID-ANR27>3.3.CO

[8]

2-4

[9] Thalidomide: Current and potential clinical applications [J].

Calabrese, L ;

Fleischer, AB .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495

[10]

Canete JD, 1997, BRIT J RHEUMATOL, V36, P38

← 1 2 3 4 5 6 →